These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence. Merino PM; Codner E; Cassorla F Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):590-8. PubMed ID: 22218441 [TBL] [Abstract][Full Text] [Related]
30. Comparison of PCOS phenotypes in adolescent and young adult Mediterranean women with possible PCOS. Fruzzetti F; Baldari F; Palla G; Fidecicchi T; Carmina E J Endocrinol Invest; 2021 May; 44(5):995-1000. PubMed ID: 32839937 [TBL] [Abstract][Full Text] [Related]
31. Polycystic ovary syndrome in adolescence. Driscoll DA Ann N Y Acad Sci; 2003 Nov; 997():49-55. PubMed ID: 14644809 [TBL] [Abstract][Full Text] [Related]
32. Endocrinological markers for assessing hyperandrogenemia in women classified as having polycystic ovary syndrome (PCOS) according to the revised 2003 diagnostic criteria. Mueller A; Dittrich R; Binder H; Hoffmann I; Beckmann MW; Cupisti S Eur J Med Res; 2006 Dec; 11(12):540-4. PubMed ID: 17182367 [TBL] [Abstract][Full Text] [Related]
33. Hyperandrogenemia is implicated in both the metabolic and reproductive morbidities of polycystic ovary syndrome. Sung YA; Oh JY; Chung H; Lee H Fertil Steril; 2014 Mar; 101(3):840-5. PubMed ID: 24424368 [TBL] [Abstract][Full Text] [Related]
34. A review of polycystic ovarian syndrome in adolescents. Brewer M; Pawelczak M; Kessler M; Shah B Minerva Pediatr; 2010 Oct; 62(5):459-73. PubMed ID: 20940680 [TBL] [Abstract][Full Text] [Related]
35. Polycystic Ovary Syndrome: Common Questions and Answers. Williams T; Moore JB; Regehr J Am Fam Physician; 2023 Mar; 107(3):264-272. PubMed ID: 36920819 [TBL] [Abstract][Full Text] [Related]
36. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study. Dalamaga M; Papadavid E; Basios G; Vaggopoulos V; Rigopoulos D; Kassanos D; Trakakis E J Am Acad Dermatol; 2013 Dec; 69(6):922-30. PubMed ID: 24120563 [TBL] [Abstract][Full Text] [Related]
37. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. Azziz R J Clin Endocrinol Metab; 2006 Mar; 91(3):781-5. PubMed ID: 16418211 [TBL] [Abstract][Full Text] [Related]
38. Use of Successive Pharmacologic Hormone Suppression Testing for a Severe Presentation of Adolescent Polycystic Ovarian Syndrome: A Case Report. Ravi SJ; Cree-Green M J Investig Med High Impact Case Rep; 2019; 7():2324709619850215. PubMed ID: 31113263 [TBL] [Abstract][Full Text] [Related]
39. Use of community-based reference ranges to estimate the prevalence of polycystic ovary syndrome by the recognised diagnostic criteria, a cross-sectional study. Skiba MA; Bell RJ; Herbert D; Garcia AM; Islam RM; Davis SR Hum Reprod; 2021 May; 36(6):1611-1620. PubMed ID: 33846715 [TBL] [Abstract][Full Text] [Related]
40. Association of Self-Reported Polycystic Ovary Syndrome, Obesity, and Weight Gain From Adolescence to Adulthood With Hypertensive Disorders of Pregnancy: A Community-Based Approach. Rantakallio JSS; Nevalainen JE; West SI; Ollila MM; Puukka K; Bloigu AH; Järvelin MR; Tapanainen JS; Franks S; Dunkel L; Piltonen TT; Vääräsmäki MS; Morin-Papunen LC Hypertension; 2021 Mar; 77(3):1010-1019. PubMed ID: 33517680 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]